A 38-year-old primigravid woman underwent amniocentesis at 20 weeks of gestation because of advanced maternal age. Her husband was 35 years old and healthy. There was no family history of attention deficit hyperactivity disorder (ADHD). Amniocentesis revealed cytogenetically detectable multiple extra bands between the regions of 4q12 and 4q21.1 in one aberrant chromosome 4. Level II ultrasound findings of the male fetus were unremarkable. Parental cytogenetic analysis revealed that the father had the same chromosome aberration, which was directly transmitted to the fetus (Fig. 1) . Oligonucleotide-based array comparative genomic hybridization (aCGH) analysis using CytoChip Oligo Array (BlueGnome, Cambridge, UK) was applied in the paternal blood. The result of aCGH revealed five copies of the 4.41-Mb euchromatic region of 4q12-q13.1 or arr cgh 4q12q13.1 (57,966,988e62,377,421)Â5 according to NCBI Build 36, March 2006, UCSC hg18 (Fig. 2) . The 4.41-Mb segment containing the LPHN3 gene had been quadruplicated in the aberrant chromosome 4. For fluorescence in situ hybridization (FISH) determination of the quadruplication, the bacterial artificial chromosome clone probes mapping the genomic region of 4q13.1 and a control probe mapping 4p16.3 were used. The bacterial artificial chromosome clone probes RP11-74H5 (red signal, 61,998,695e62,149,756 at 4q13.1) and RP11-69L7 (green signal, internal control, 752,790e906,783 at 4p16.3) were used to determine the quadruplication. Interphase FISH (Fig. 3) showed five red signals and two green signals with four signals closing together. The result was consistent with the aCGH result and indicated quadruplication of 4q13.1 in the aberrant chromosome. Metaphase FISH (Fig. 4) showed multiple amplifications of the red signals in the aberrant chromosome. The parents decided to continue the pregnancy after genetic counseling. At 38 weeks of gestation, a healthy 3045-g male baby was delivered uneventfully. Pediatric follow-ups at 1 month of age showed normal development and no phenotypic abnormalities in the baby. The karyotype of the father and the son was 46,XY,qdp(4)(q12q13.1). Directly transmitted unbalanced chromosome abnormalities (UBCAs) and euchromatic variants (EVs) may be detected at prenatal diagnosis [1, 2] . In instance of UBCAs, copy number of one or more genes is either reduced or increased, whereas in instance of EVs, copy number variation of segment contains paralogous genes and pseudogenes and is polymorphic in the normal population and cytogenetically detectable [1] . The reported EVs include 8p23.1, 9p12, 9q12, 15q11.2, and 16p11.2. In 70 families with directly transmitted EVs, Barber [1] found that 54% (38/70) had no phenotypic effect, 43% (30/70) had affected probands and phenotypically normal family members, and 3% (2/70) had consistent mild phenotypic anomalies. In contrast, in 130 families with directly transmitted UBCAs, Barber [1] found that 18% (23/ 130) had no phenotypic effect, 23% (30/130) had affected probands and phenotypically normal family members, and 59% (77/130) had consistent mild phenotypic anomalies. In a review of chromosome 4, Barber [1] found dup(4)(q31.3-q33) in the category of Group 2 in which the phenotypically unaffected parents had the same UBCA as their affected children, and del(4)(p15.2-p16.1), del(4)(q33-qter), del(4)(q33-q35.1), del(4)(q33-q33), del(4)(q32-q33), dup(4)(q31.22-q33), and dup(4)(q31.3-q32.3) in the category of Group 3 in which the phenotypically affected parents had the same UBCA as their affected children. Rodríguez et al [10] additionally reported a 3.3-Mb interstitial duplication of 4p16.1 in a phenotypically normal father and a healthy 5-year-old daughter.
Our case is the first report of directly transmitted UBCA involving tandem segmental amplifications of the 4q12-q13.1 segment and the LPHN3 gene. Clinical information regarding duplication involving the proximal region of 4q is very little. Mattei et al [3] first reported a 6-year-old girl with dup(4)(q12/q13) resulting from an insertion of 4q12-q13 into a chromosome 18 because of a maternal complex chromosome rearrangement with translocation between chromosomes 2 and 4 in addition to an insertion of 4q12-q13 into the long arm of chromosome 18. The girl manifested short stature, psychomotor retardation, microcephaly, expicanthic folds, a broad nose, a large mouth, a left preauricular fistula, and clinodactyly. Shashi et al [4] reported a 2-year-8-monthold boy with a dup(4)(q12q13), microcephaly, mental retardation, and minor facial anomalies. However, the present case did not have phenotypic abnormalities, indicating a benign nature of gene dosage increase of the LPHN3. LPHN3 or latrophilin 3 gene encodes a member of the latrophilin subfamily of G-protein coupled receptors responsible for mediating extracellular to intracellular signaling. Recent studies have suggested LPHN3 is a candidate gene for ADHD [5e8], and LPHN3 common variants of LPHN3 confer susceptibility to ADHD [5, 8, 9 ]. The present case had gene dosage increase of the LPHN3 gene but manifested no phenotype of ADHD. The aCGH study to define the exact nature of gene dosage increase of the LPHN3 gene in our UBCA carrier will provide us relevant information for genetic counseling concerning tandem segmental amplifications of 4q12-q13.1. 
